Cargando…
HIV-1 RT Inhibitors with a Novel Mechanism of Action: NNRTIs that Compete with the Nucleotide Substrate
HIV-1 reverse transcriptase (RT) inhibitors currently used in antiretroviral therapy can be divided into two classes: (i) nucleoside analog RT inhibitors (NRTIs), which compete with natural nucleoside substrates and act as terminators of proviral DNA synthesis, and (ii) non-nucleoside RT inhibitors...
Autores principales: | Maga, Giovanni, Radi, Marco, Gerard, Marie-Aline, Botta, Maurizio, Ennifar, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185657/ https://www.ncbi.nlm.nih.gov/pubmed/21994659 http://dx.doi.org/10.3390/v2040880 |
Ejemplares similares
-
Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
por: Vanangamudi, Murugesan, et al.
Publicado: (2023) -
Computational studies on non-nucleoside analogs of pyrimidine as NNRTIs against HIV-1
por: Srivastava, Ritika, et al.
Publicado: (2014) -
Computational modelling, green synthesis and biological activity of arylsulfonilamides as NNRTIs against HIV-1
por: Singh, Anuradha, et al.
Publicado: (2014) -
Design and
Synthesis of Novel HIV-1 NNRTIs
with Bicyclic Cores and with Improved Physicochemical Properties
por: Prener, Ladislav, et al.
Publicado: (2023) -
Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years
por: Zhuang, Chunlin, et al.
Publicado: (2020)